- Home
- ONMD vs FGEN Comparison
ONMD vs FGEN Comparison
Compare ONMD & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- FGEN
- Stock Information
- Founded
- ONMD 2006
- FGEN 1993
- Country
- ONMD United States
- FGEN United States
- Employees
- ONMD N/A
- FGEN N/A
- Industry
- ONMD
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ONMD
- FGEN Health Care
- Exchange
- ONMD Nasdaq
- FGEN Nasdaq
- Market Cap
- ONMD 32.5M
- FGEN 34.5M
- IPO Year
- ONMD N/A
- FGEN 2014
- Fundamental
- Price
- ONMD $0.70
- FGEN $0.43
- Analyst Decision
- ONMD
- FGEN Strong Buy
- Analyst Count
- ONMD 0
- FGEN 1
- Target Price
- ONMD N/A
- FGEN $10.00
- AVG Volume (30 Days)
- ONMD 51.1K
- FGEN 8.2M
- Earning Date
- ONMD 12-17-2024
- FGEN 05-05-2025
- Dividend Yield
- ONMD N/A
- FGEN N/A
- EPS Growth
- ONMD N/A
- FGEN N/A
- EPS
- ONMD 0.01
- FGEN N/A
- Revenue
- ONMD $957,651.00
- FGEN $180,015,000.00
- Revenue This Year
- ONMD N/A
- FGEN $22.77
- Revenue Next Year
- ONMD N/A
- FGEN N/A
- P/E Ratio
- ONMD $87.64
- FGEN N/A
- Revenue Growth
- ONMD 1.36
- FGEN 16.15
- 52 Week Low
- ONMD $0.46
- FGEN $0.18
- 52 Week High
- ONMD $3.37
- FGEN $2.80
- Technical
- Relative Strength Index (RSI)
- ONMD 33.54
- FGEN 46.25
- Support Level
- ONMD $0.57
- FGEN $0.36
- Resistance Level
- ONMD $0.77
- FGEN $0.49
- Average True Range (ATR)
- ONMD 0.09
- FGEN 0.06
- MACD
- ONMD -0.01
- FGEN -0.00
- Stochastic Oscillator
- ONMD 27.08
- FGEN 29.46
Stock Price Comparison Chart: ONMD vs FGEN
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.